Economy Catches Up With Varian Oncology Sales; Medicare Cuts Also Loom
This article was originally published in The Gray Sheet
Executive Summary
Radiotherapy device marketer Varian Medical Systems is finally feeling the pinch of the recession and could face more pricing pressures in the coming year, the firm indicated during its July 29 third quarter earnings call
You may also be interested in...
Imaging Use Assumption Increase Crops Up In Physician Fee Proposal
Whether or not Congress fulfills promises to enact medical imaging physician payment cuts next year, CMS said July 1 that it plans to do just that through its own administrative means
Varian Skirts Tight Credit Market With RapidArc Sales On The Rise
Varian Medical Systems maintains that the current weak economic environment is not likely to have an impact on sales of its RapidArc cancer radiation therapy system
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.